Epilepsy trials recruiting in Utah

All Epilepsy trials nationally

Cities in Utah

Recruiting trials in Utah

• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
  NCT06872125 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Utah: Salt Lake City
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
  NCT05716100 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Utah: Salt Lake City
• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
  NCT04462770 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Utah: Salt Lake City
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
  NCT06132893 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Utah: Salt Lake City
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
  NCT05667142 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Utah: Salt Lake City
• An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
  NCT05066217 · Phase: Phase 3 · Ages: 2 Years to 55 Years · Sex: All (male and female) · Utah: Salt Lake City
• Capturing Autobiographical Memory Formation in Real World Spaces Using Multimodal Recordings
  NCT06883981 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Utah: Salt Lake City
• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
  NCT05135091 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Utah: Salt Lake City
• Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
  NCT05283811 · Phase: Not applicable (e.g. observational or device study) · Ages: 10 Years to 64 Years · Sex: All (male and female) · Utah: Salt Lake City
• VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems
  NCT03953768 · Phase: Not applicable (e.g. observational or device study) · Ages: 0 Years to 60 Years · Sex: All (male and female) · Utah: Salt Lake City